AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyfic M 80mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Indizen Pharmaceutical

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glyfic M 80mg/500mg Tablet ER

Metformin/Glimepiride extended-release tablets (80mg/500mg) are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This dual-action therapy helps regulate blood glucose levels. These tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical guidance can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices are essential for diabetes control. Common adverse reactions include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant kidney/liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glyfic M 80mg/500mg Tablet ER

Adult-onset diabetes

Major Benefits of Glyfic M 80mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glyfic M 80mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Consume this medication with food.

Common Side effects of Glyfic M 80mg/500mg Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glyfic M 80mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glyfic M 80mg/500mg Extended-Release tablets should be administered with food.

How Glyfic M 80mg/500mg Tablet ER works:

Glyfic M 80mg/500mg extended-release tablets contain gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glyfic M 80mg/500mg Extended-Release tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glyfic M 80mg/500mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glyfic M 80mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glyfic M 80mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glyfic M 80mg/500mg Extended-Release tablet use. Physician consultation is necessary. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyfic M 80mg/500mg Tablet ER cautiously, potentially requiring dose modification. Consult a physician before use. In those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in severe cases.

What if you forget to take Glyfic M 80mg/500mg Tablet ER :

Should you forget a Glyfic M 80mg/500mg Tablet ER dose, take it immediately if you remember. Otherwise, omit the missed dose if your next scheduled dose is imminent and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glyfic M 80mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glyfic M 80mg/500mg Tablet ER

Glyfic M 80mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for treating type 1 diabetes.
Glyfic M 80mg/500mg ER tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glyfic M 80mg/500mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glyfic M 80mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Glyfic M 80mg/500mg Tablet ER and seek immediate medical attention.
Prolonged use of Glyfic M 80mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glyfic M 80mg/500mg Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Glyfic M 80mg/500mg ER tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glyfic M 80mg/500mg Extended-Release tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glyfic M is not suitable for type 1 diabetes.
Glyfic M 80mg/500mg Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glyfic M 80mg/500mg ER Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glyfic M 80mg/500mg Tablet ER can cause lactic acidosis (MALA), a serious, though rare, complication of metformin. This medical emergency results from excessive lactic acid in the bloodstream. It's crucial to avoid use in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glyfic M and seek immediate medical attention.
Prolonged Glyfic M 80mg/500mg Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance difficulties), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake is recommended annually, according to some research.
Glyfic M 80mg/500mg Tablet ER is contraindicated in patients with known allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glyfic M 80mg/500mg Tablet ER and alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glyfic M 80mg/500mg Table...
70
MRP 85
17% off